✦ LIBER ✦

Persistence of antibody after hepatitis B vaccine and the question of boosters

✍ Scribed by Edward Tabor

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 149 KB
Volume: 41
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.20606

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Modelling long-term persistence of hepat

Modelling long-term persistence of hepatitis B antibodies after vaccination

✍ Vellinga, A.; Van Damme, P.; Bruckers, L.; Weyler, J.J.; Molenberghs, G.; Meheus 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

Antibody response to hepatitis B vaccination was measured in 97 institutionalized, mentally handicapped patients after a 0-, 1-, 6-month vaccination schedule. Two groups were formed at month 7 according to the antibody response, which determined whether they needed an additional vaccine dose at mont

Characterization of a human monoclonal a

Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant-DNA hepatitis B vaccine

✍ R.A. Heijtink; J. Kruining; P. van Bergen; S. de Rave; J. van Hattum; M. Schutte 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

A human monoclonal antibody type IgG4, designated 1Ff4, was obtained by Epstein Barr virus transformation of peripheral blood lymphocytes from a hepatitis B vaccinee (HB-VAX: plasmaderived vaccine) after one boost of yeast recombinant DNA derived vaccine (Engerix-B). 1Ff4 binds preferentially to HBs

The Persistence of Hepatitis A IgM Antib

The Persistence of Hepatitis A IgM Antibody After Acute Clinical Hepatitis A

✍ Henry W. Kao; Mary Ashcavai; Allan G. Redeker 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

Hepatitis A IgM antibody (IgM anti-HAV), detected by commercially available solid-phase radioimmunoassay, is an accepted marker of acute viral hepatitis A infection. However, persistence of this serological marker far beyond the acute illness and immediate convalescent period has been reported. To d

Waning immunity to plasma-derived hepati

Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination

✍ Chun-Yi Lu; Bor-Luen Chiang; Wei-Kuang Chi; Mei-Hwei Chang; Yen-Hsuan Ni; Hsu-Me 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Persistence of IgM hepatitis A antibody

Persistence of IgM hepatitis A antibody after clinical type A hepatitis

✍ Ding-Shinn Chen; Juei-Low Sung; Henry W. Kao; Mary Ashcavai; Allan G. Redeker 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

still find a highly significant positive correlation between the degree of architectural destruction and W-FHVP (r = 0.67, p < 0.001).

Mathematical models for assessment of lo

Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines

✍ Van Herck, K.; Beutels, P.; Van Damme, P.; Beutels, M.; Van den Dries, J.; Brian 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

Very few studies with inactivated hepatitis A vaccines were designed for long-term follow-up of antibody persistence. Based on the serological data from these vaccine trials, mathematical models were developed to predict the decrease of anti-hepatitis A virus (anti-HAV) antibodies after vaccination.